Table 2.
All participants (n = 657) |
Disease-free reference population (n = 533) |
|||||
---|---|---|---|---|---|---|
Baseline | Δ over time | % Δ | Baseline | Δ over time | % Δ | |
TSH (mU/liter) | 2.6 (3.6) | 0.34 (2.3)a | +13% | 2.3 (1.4) | 0.28 (1.4)a | +12% |
FT4 (ng/dl) | 1.2 (0.2) | 0.02 (0.18)a | +1.7% | 1.2 (0.2) | 0.03 (0.17)a | +2.5% |
Total T3 (ng/dl) | 116.9 (19.5) | −14.9 (20.8)a | −13% | 116.9 (19.5) | −14.9 (19.5)a | −13% |
TPOAb+ (%) | 8.6 | 0.52 | +6.0% |
Baseline values are mean (sd) unless otherwise noted. All participants includes participants with values from both baseline and All-Stars examination reporting no thyroid hormone use at either visit. Disease-free reference population additionally excludes participants with overt hypo- or hyperthyroidism or TPOAb positivity at either visit. To convert FT4 to nanomoles per liter, multiply by 12.87. To convert total T3 to nanomoles per liter, multiply by 0.0154.
P < 0.05.